Improved selection of patients for hepatic surgery of colorectal liver metastases with FDG-PET: A randomized study
2008-01-01 Wiering, B; Oyen, W; Van der Sijp, J; Roumen, R; De Jong, K; Comans, E; Pruim, J; Dekker, H; Krabbe, P; Ruers, T
SPECT/CT imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1 antibodies
2015-01-01 Heskamp, S; Hobo, W; Molkenboer-Kuenen, J; Olive, D; Oyen, W; Dolstra, H; Boerman, O
Tc-99m-CXCL8 SPECT to image disease activity in inflammatory bowel disease
2015-01-01 Aarntzen, E; De Jong, D; Hermsen, R; Drenth, J; Boerman, O; Oyen, W
The value of fdg-pet/ct in diagnosis and during follow-up of 271 patients suspected of chronic q fever.
2016-01-01 Kouijzer, I; Kampschreur, L; Hoekstra, C; Van Kasteren, M; Leclercq, M; Nabuurs-Franssen, M; Wegdam, M; De Geus-Oei, Lf; Oyen, W; Bleeker-Rovers, C
Zirconium-89-girentuximab PET/CT imaging in renal cell carcinoma: first in man results
2016-01-01 Hekman, M; Rijpkema, M; Mulders, P; Oosterwijk, E; Boerman, O; Oyen, W
A direct comparison of four Ga-68-labelled RGD peptides to image alpha(v)beta(3) integrin expression in a human tumour xenograft mouse model
2016-01-01 Lobeek, D; Franssen, Gm; Molkenboer-Kuenen, Jdm; Eek, A; Rijpkema, M; Ma, Mt; Wester, H; Decristoforo, C; Terry, Sya; Oyen, W; Boerman, Oc
Diagnostic delay in primary osteosarcoma (OST) and Ewing sarcoma (ES) of bone in relation to metabolic activity on FDG PET/CT
2017-01-01 Van de Luijtgaarden, A; Usmanij, E; De Geus-Oei, Lf; De Rooy, J; Flucke, U; Kaal, S; Van Riel, C; Schreuder, B; Oyen, W; Van der Graaf, W
CD103+/PD-1+T-cells identify a subset of triple-negative breast cancer eligible for targeted checkpoint inhibition
2016-01-01 Bottai, G; Roncalli, M; Santarpia, L
ADJUVANT RADIOTHERAPY HAS A POSITIVE IMPACT ON CANCER-SPECIFIC SURVIVAL OF LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS. RESULTS OF A MATCHED ANALYSIS OF A TWO-INSTITUTION SERIES WITH 703 LYMPH NODE POSITIVE PATIENTS
2009-01-01 Briganti, A; Karnes, Jr; Da Pozzo, Lf; Suardi, N; Gallina, A; Cozzarini, C; Freschi, M; Guazzoni, G; Rigatti, P; Montorsi, M; Blute, Ml
Radioimmunotherapy prevents anastomotic relapse of colorectal cancer in a rat model
2008-01-01 de Long, G; Hendriks, T; Oyen, W; Aarts, F; Bleichrodt, Rp; Boerman, Oc
Radioimmunotherapy Prevents Anastomotic Relapse of Colorectal Cancer in a Rat Model
2008-01-01 de Jong, Gm; Hendriks, T; Oyen, W; Aarts, F; Bleichrodt, Rp; Boerman, Oc
Kidney protection during peptide receptor radionuclide therapy (PRRT)
2009-01-01 Melis, M; Rolleman, Ej; Vegt, E; Gotthardt, M; Oyen, W; Krenning, Ep; Boerman, Oc; De Jong, M
Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin
2009-01-01 De Jong, G; Hendriks, T; Oyen, W; Heskamp, S; Eek, A; Bleichrodt, R; Boerman, O
F-18-FDG-PET/CT as a diagnostic tool in native valve endocarditis
2017-01-01 Kouijzer, I; Berrevoets, M; Aarntzen, E; Janssen, M; de Vries, J; van Dijk, A; Oyen, W; de Geus-Oei, L; Bleeker-Rovers, C
PET/CT imaging of angiogenesis in head and neck squamous cell carcinoma patients
2017-01-01 Lobeek, D; Terry, Sya; Merkx, Maw; Takes, Rp; Slootweg, Pj; Oyen, W; Boerman, Oc; Rijpkema, M
EANM/EARL FDG-PET/CT accreditation - summary results from the first 150 accredited imaging sites
2017-01-01 Kaalep, A; Sera, T; Oyen, W; Krause, Bj; Chiti, A; Liu, Y; Boellaard, R
Brain F-18-Choline PET/CT: a first interim analysis of the impact on clinical management in patients with brain lymphoma
2018-01-01 Santos, Aaf; Du, Y; Zerizer, I; Murray, I; Ruas, A; Abreu, C; Meintjes, M; Chua, S; Oyen, W
Radiation Exposure (Un)Awareness amongst nuclear medicine patients - a systematic review
2018-01-01 Ribeiro, Asf; Husson, O; Drey, N; Murray, I; May, K; Flux, G; Oyen, W
Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)
2018-01-01 Verhoeff, Sr; Es, S; Boon, E; van Helden, E; Angus, L; Elias, S; Oosting, S; Aarntzen, E; Brouwers, A; Heskamp, S; Hoekstra, Os; Verheul, Hm; Van der Veldt, Aam; de Vries, Ege; Boerman, O; van der Graaf, Wta; Oyen, W; van Herpen, Cml
Establishing a GMP-compliant 89-Zirconium radiopharmaceutical production capability at the Royal Marsden Hospital Foundation Trust, UK
2019-01-01 Tan, J; Da Pieve, C; Smith, G; Turton, D; Oyen, W
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Improved selection of patients for hepatic surgery of colorectal liver metastases with FDG-PET: A randomized study | 1-gen-2008 | Wiering, B; Oyen, W; Van der Sijp, J; Roumen, R; De Jong, K; Comans, E; Pruim, J; Dekker, H; Krabbe, P; Ruers, T | |
| SPECT/CT imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1 antibodies | 1-gen-2015 | Heskamp, S; Hobo, W; Molkenboer-Kuenen, J; Olive, D; Oyen, W; Dolstra, H; Boerman, O | |
| Tc-99m-CXCL8 SPECT to image disease activity in inflammatory bowel disease | 1-gen-2015 | Aarntzen, E; De Jong, D; Hermsen, R; Drenth, J; Boerman, O; Oyen, W | |
| The value of fdg-pet/ct in diagnosis and during follow-up of 271 patients suspected of chronic q fever. | 1-gen-2016 | Kouijzer, I; Kampschreur, L; Hoekstra, C; Van Kasteren, M; Leclercq, M; Nabuurs-Franssen, M; Wegdam, M; De Geus-Oei, Lf; Oyen, W; Bleeker-Rovers, C | |
| Zirconium-89-girentuximab PET/CT imaging in renal cell carcinoma: first in man results | 1-gen-2016 | Hekman, M; Rijpkema, M; Mulders, P; Oosterwijk, E; Boerman, O; Oyen, W | |
| A direct comparison of four Ga-68-labelled RGD peptides to image alpha(v)beta(3) integrin expression in a human tumour xenograft mouse model | 1-gen-2016 | Lobeek, D; Franssen, Gm; Molkenboer-Kuenen, Jdm; Eek, A; Rijpkema, M; Ma, Mt; Wester, H; Decristoforo, C; Terry, Sya; Oyen, W; Boerman, Oc | |
| Diagnostic delay in primary osteosarcoma (OST) and Ewing sarcoma (ES) of bone in relation to metabolic activity on FDG PET/CT | 1-gen-2017 | Van de Luijtgaarden, A; Usmanij, E; De Geus-Oei, Lf; De Rooy, J; Flucke, U; Kaal, S; Van Riel, C; Schreuder, B; Oyen, W; Van der Graaf, W | |
| CD103+/PD-1+T-cells identify a subset of triple-negative breast cancer eligible for targeted checkpoint inhibition | 1-gen-2016 | Bottai, G; Roncalli, M; Santarpia, L | |
| ADJUVANT RADIOTHERAPY HAS A POSITIVE IMPACT ON CANCER-SPECIFIC SURVIVAL OF LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS. RESULTS OF A MATCHED ANALYSIS OF A TWO-INSTITUTION SERIES WITH 703 LYMPH NODE POSITIVE PATIENTS | 1-gen-2009 | Briganti, A; Karnes, Jr; Da Pozzo, Lf; Suardi, N; Gallina, A; Cozzarini, C; Freschi, M; Guazzoni, G; Rigatti, P; Montorsi, M; Blute, Ml | |
| Radioimmunotherapy prevents anastomotic relapse of colorectal cancer in a rat model | 1-gen-2008 | de Long, G; Hendriks, T; Oyen, W; Aarts, F; Bleichrodt, Rp; Boerman, Oc | |
| Radioimmunotherapy Prevents Anastomotic Relapse of Colorectal Cancer in a Rat Model | 1-gen-2008 | de Jong, Gm; Hendriks, T; Oyen, W; Aarts, F; Bleichrodt, Rp; Boerman, Oc | |
| Kidney protection during peptide receptor radionuclide therapy (PRRT) | 1-gen-2009 | Melis, M; Rolleman, Ej; Vegt, E; Gotthardt, M; Oyen, W; Krenning, Ep; Boerman, Oc; De Jong, M | |
| Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin | 1-gen-2009 | De Jong, G; Hendriks, T; Oyen, W; Heskamp, S; Eek, A; Bleichrodt, R; Boerman, O | |
| F-18-FDG-PET/CT as a diagnostic tool in native valve endocarditis | 1-gen-2017 | Kouijzer, I; Berrevoets, M; Aarntzen, E; Janssen, M; de Vries, J; van Dijk, A; Oyen, W; de Geus-Oei, L; Bleeker-Rovers, C | |
| PET/CT imaging of angiogenesis in head and neck squamous cell carcinoma patients | 1-gen-2017 | Lobeek, D; Terry, Sya; Merkx, Maw; Takes, Rp; Slootweg, Pj; Oyen, W; Boerman, Oc; Rijpkema, M | |
| EANM/EARL FDG-PET/CT accreditation - summary results from the first 150 accredited imaging sites | 1-gen-2017 | Kaalep, A; Sera, T; Oyen, W; Krause, Bj; Chiti, A; Liu, Y; Boellaard, R | |
| Brain F-18-Choline PET/CT: a first interim analysis of the impact on clinical management in patients with brain lymphoma | 1-gen-2018 | Santos, Aaf; Du, Y; Zerizer, I; Murray, I; Ruas, A; Abreu, C; Meintjes, M; Chua, S; Oyen, W | |
| Radiation Exposure (Un)Awareness amongst nuclear medicine patients - a systematic review | 1-gen-2018 | Ribeiro, Asf; Husson, O; Drey, N; Murray, I; May, K; Flux, G; Oyen, W | |
| Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) | 1-gen-2018 | Verhoeff, Sr; Es, S; Boon, E; van Helden, E; Angus, L; Elias, S; Oosting, S; Aarntzen, E; Brouwers, A; Heskamp, S; Hoekstra, Os; Verheul, Hm; Van der Veldt, Aam; de Vries, Ege; Boerman, O; van der Graaf, Wta; Oyen, W; van Herpen, Cml | |
| Establishing a GMP-compliant 89-Zirconium radiopharmaceutical production capability at the Royal Marsden Hospital Foundation Trust, UK | 1-gen-2019 | Tan, J; Da Pieve, C; Smith, G; Turton, D; Oyen, W |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2151
Data di pubblicazione
- 2020 - 2026113
- 2010 - 20191340
- 2000 - 2009587
- 1990 - 1999110
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY123
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...120
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE100
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY59
- ANNALS OF ONCOLOGY57
- JOURNAL OF CLINICAL ONCOLOGY45
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng794
- ita24
- und6
Accesso al fulltext
- no fulltext2098
- reserved51
- open2